Tuesday, August 9, 2022

Japanese drugmaker to launch first-ever plant-based Covid vax

Tokyo: Japanese pharmaceutical group Mitsubishi Tanabe Pharma is planning to launch the first-ever plant-based Covid-19 vaccine in the world, which will likely to be of low-cost, easier to transport as well as store than the conventional jabs, the media reported.

The vaccine candidate will be developed by the Osaka-based company’s subsidiary Medicago from a plant from the tobacco family by December 2021, the Financial Times reported.

The vaccine technology here is formed with virus-like particles that mimic the target virus and does not actually use a live virus, unlike some of the current vaccines and can thus be deemed relatively safe for humans.

With this new technique, the Japanese pharmaceutical group aims to break into a market which is dominated by major drugmakers Pfizer, Moderna and AstraZeneca.

However, as new strains of the virus continue to emerge, they expect global demand for Covid vaccines to remain strong, the report noted.

“As with seasonal flu, we don’t expect demand [for Covid-19 vaccines] to suddenly disappear and there is still much uncertainty regarding emerging variants,” Toshifumi Tada, head of vaccine business development at Mitsubishi was quoted as saying.

“We believe there is value in expanding options for vaccines,” Tada added.

So far, no plant-based vaccine has been approved for use in humans. But the prospects of such a jab seems viable as plant leaves grow quickly, cutting down the manufacturing process as well as costs.

Medicago’s vaccine can be produced in five to eight weeks, compared to a traditional seasonal flu vaccine that takes about eight months to a year to produce.

Faster production, the report added, will also make it easier to adapt to combat new strains.

Moreover, plant-based vaccines do not need to be deep frozen during transport since Medicago’s vaccine can be stored at temperatures of 2 degrees Celsius to 8 degrees Celsius, the report said.

Medicago is partnering with UK-based GlaxoSmithKline for the vaccine adjuvant, and is analysing phase-3 trial data for the Covid-19 vaccine involving 24,000 subjects in Canada, the US, the UK, Brazil, Argentina and Mexico.

It also began a smaller-scale clinical trial this month in Japan, where it hopes to apply for regulatory approval by March. No serious side-effects have been reported related to its vaccine candidate, according to trial results, the report said.

The company plans to produce about 80 million doses at its plant in North Carolina, US, and aims to raise its annual capacity to 1 billion doses, once its new plant in Quebec City, Canada, begins operations in 2024.

(IANS)

Related Articles

Amit Shah offers prayer at Lingaraj Temple

0
Bhubaneswar: Union Home Minister Amit Shah, who is on a two-day visit to Odisha, visited Lingaraj temple amid tight security and offered prayer to...

Under-trial prisoner slits throat at Jharsuguda sub-jail

0
Jharsuguda, : An under-trial prisoner attempted suicide by slitting his throat with a blade at Jharsuguda sub-jail on Sunday. He was first rushed to the...

IMD Issues Very Heavy Rainfall Alert For Odisha

0
Bhubaneswar: The low pressure formed over the Bay of Bengal that has become well marked is likely to concentrate into a depression during next 48...

Delhites Swayed by Nitya’s Bharatnatyam Performance

0
New Delhi, .: Young and upcoming danseuse Nitya Khandelwal enthralled the art lovers of Delhi by her scintillating Bharatnatyam dance recital recently. The maiden...

Jagdeep Dhankar declared Vice President of India

0
New Delhi, : Former Governor of West Bengal and NDA candidate Jagdeep Dhankhar on Saturday defeated Opposition nominee Margaret Alva to become the 16th...

ED brings Partha Chatterjee’s daughter, son-in-law under scanner

0
Kolkata, : The Enforcement Directorate (ED) probing the multi-crore West Bengal School Service Commission (WBSSC) recruitment irregularities scam has now brought Partha Chatterjee’s daughter...

Industrialist Mahima Mishra appears before CBI

0
Bhubaneswar, :  Industrialist Mahimananda Mishra (popularly known as Mahima Mishra) appeared before the Central Investigation Agency (CBI) in its Bhubaneswar office on Friday a...

Class X girl found pregnant in Malkangiri residential school, youth held

0
Malkangiri, : In a bizarre incident, a class X student was found pregnant in Ekalavya Residential School at Champanagar in Malkangiri district. After the...

Physical Education teacher under vigilance scanner on Ganjam

0
Berhampur, : Vigilance sleuths today conducted simultaneous raids at several places linked to a physical education teacher of Jayantipur high school in Ganjam district. The...

Leopard Skin Seized From Kandhamal , 1 Arrested

0
Kandhamal: On the basis of reliable information, a team of Special Task Force (STF) conducted raid with the help of Tikabali Forest Officials of Kandhamal...

Odia film director Nishi Kar passes away

0
Bhubaneswar, : Ollywood director Nishi Kar passed away in a road accident late on Tuesday night. He was 38. As per reports, he died on...

Vigilance apprehends Balipatna ASI for taking bribe

0
Khordha, : The Vigilance sleuths on Wednesday apprehended Assistant Sub Inspector (ASI) of Balipatna Police Station here while demanding and accepting a bribe of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

22,878FansLike
3,429FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

- Advertisement -